We are live on ! Find out more
ICCC icon

ImmuCell

28 hedge funds and large institutions have $7.45M invested in ImmuCell in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $7.2M → $7.45M (+$255K)

0% more funds holding

Funds holding: 2828 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.22% less ownership

Funds ownership: 10.36%10.14% (-0.22%)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
28
Holders Change
Holders Change %
0%
% of All Funds
0.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
5
Reduced
7
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
HI
26
Harbour Investments
Wisconsin
$2K
Northwestern Mutual Wealth Management
27
Northwestern Mutual Wealth Management
Wisconsin
$1K
WCM
28
Wedge Capital Management
North Carolina
-$197K -20,384 Closed
Wells Fargo
29
Wells Fargo
California
+$20 +2 +6%

ICCC Hedge Fund Activity: Q2 2021 in Review

28 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q2 2021, worth a combined $7.45M — up 3.5% from $7.2M a quarter earlier.

Fund positioning in ICCC was balanced in Q2 2021: 1 fund opened new positions, 1 closed out, 5 added to existing stakes and 7 trimmed.

The largest buyer was Bleichroeder LP, opening a new position worth an estimated $591K. The largest seller was Wedge Capital Management, exiting entirely with an estimated $197K sold.

  • 28 institutional investors held ImmuCell (ICCC) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $7.45M of ImmuCell stock for Q2 2021, up 3.5% quarter-over-quarter.
  • 1 fund opened new ImmuCell positions in Q2 2021 and 1 closed out, a net change of 0 holders.
  • The largest ImmuCell buyer in Q2 2021 was Bleichroeder LP, an estimated $591K added.
  • The largest ImmuCell seller in Q2 2021 was Wedge Capital Management, an estimated $197K sold.

Based on aggregated 13F filings for Q2 2021.